Plenary Lecture
Plenary Talk I
October 15 (Wed), 17:40-18:30, Convention Hall 1, 3F
Dr. Insuk Lee
(Yonsei University)
Title
Human reference microbiome for the era of microbiome medicine
Human reference microbiome for the era of microbiome medicine
Bio
Insuk Lee is a Underwood Distinguished Professor in the Department of Biotechnology at Yonsei University. He earned his B.S. in Biology from Hanyang University and his Ph.D. in Microbiology from the University of Texas at Austin. He subsequently conducted postdoctoral research at the Center for Systems Biology at the same institution.
Since joining Yonsei in 2008, Dr. Lee has focused on network biology, cancer systems biology, single-cell omics, computational metagenomics, and the human microbiome. His notable contributions include the development of genome-scale functional networks for 5 animal, 7 plant, and 7 microbial species including humans, as well as network medicine research tools (https://netbiolab.org/w/Software). He also developed TRRUST, one of the most widely used TF-target network databases, which has been cited over 1,800 times.
His recent publications reflect his expertise in genome-resolved metagenomics and functional analysis of the human microbiome. Dr. Lee has received numerous honors, including the POSCO TJ Park Junior Faculty Fellowship (2010), KSBI OnBIT Award (2011), Yonsei Faculty Research Award (2014, 2021), Yonsei Academic Award (2022), and Yonsei Golden Citation Award (2025). He served as President of the Korean Society for Bioinformatics (2023–2024) and as an Advisory Committee Member for the National AI Commission (2024–2025).
Insuk Lee is a Underwood Distinguished Professor in the Department of Biotechnology at Yonsei University. He earned his B.S. in Biology from Hanyang University and his Ph.D. in Microbiology from the University of Texas at Austin. He subsequently conducted postdoctoral research at the Center for Systems Biology at the same institution.
Since joining Yonsei in 2008, Dr. Lee has focused on network biology, cancer systems biology, single-cell omics, computational metagenomics, and the human microbiome. His notable contributions include the development of genome-scale functional networks for 5 animal, 7 plant, and 7 microbial species including humans, as well as network medicine research tools (https://netbiolab.org/w/Software). He also developed TRRUST, one of the most widely used TF-target network databases, which has been cited over 1,800 times.
His recent publications reflect his expertise in genome-resolved metagenomics and functional analysis of the human microbiome. Dr. Lee has received numerous honors, including the POSCO TJ Park Junior Faculty Fellowship (2010), KSBI OnBIT Award (2011), Yonsei Faculty Research Award (2014, 2021), Yonsei Academic Award (2022), and Yonsei Golden Citation Award (2025). He served as President of the Korean Society for Bioinformatics (2023–2024) and as an Advisory Committee Member for the National AI Commission (2024–2025).
Plenary Talk II
October 16 (Thu), 13:20-14:10, Convention Hall 1, 3F
Dr. Mathias Uhlen
(KTH Royal Inst of Technology)
Title
The Human Protein Atlas - implications for drug development and precision medicine
The Human Protein Atlas - implications for drug development and precision medicine
Bio
Mathias Uhlen research is focused on protein science, antibody engineering and precision medicine. His research has resulted in more than 800 publications and he is co-founder or early investor of 30 biotech companies. Since 2003, he has led an international effort to systematically map the human proteome and transcriptome to create a Human Protein Atlas. He is member of the National Academy of Engineering (NAE) in USA, the Royal Swedish Academy of Science (KVA), the Swedish Academy of Engineering Science (IVA) and the European Molecular Biology Organization (EMBO). From 2010-2015, he was the Founding Director of the Science for Life Laboratory (SciLifeLab), a Swedish national center for molecular bioscience.
Mathias Uhlen research is focused on protein science, antibody engineering and precision medicine. His research has resulted in more than 800 publications and he is co-founder or early investor of 30 biotech companies. Since 2003, he has led an international effort to systematically map the human proteome and transcriptome to create a Human Protein Atlas. He is member of the National Academy of Engineering (NAE) in USA, the Royal Swedish Academy of Science (KVA), the Swedish Academy of Engineering Science (IVA) and the European Molecular Biology Organization (EMBO). From 2010-2015, he was the Founding Director of the Science for Life Laboratory (SciLifeLab), a Swedish national center for molecular bioscience.
